Impurity Isolation and Identification

In his presentation from IVT's 9th Annual Method Validation and Development conference, Rafail Usatinsky explains how to isolate and identify impurities in the drug development timeline. Ustatinksy discusses what needs to be determined in the initial planning and compares the concepts of isolation versus synthesis. Usatinsky also illustrated the proper methodology with an impurity isolation case study.